## NVR: NVR, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -3.3% below STRENGTH zone (3.0-6.0%); PEG 4.89 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($7022.93)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.10M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.7% (-1.0%)
- Blackrock Inc.: 10.6% (-4.1%)
- State Street Corpora: 4.7% (-1.6%)
- Capital Research Glo: 4.7% (+8.0%)
- JPMORGAN CHASE & CO: 3.0% (+108.3%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-5.9% 5d) with bearish MACD, trend may be turning.
2. Valuation stretched: PEG 4.9x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 4.89 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 35%, ROA 19%). Balance sheet: strong liquidity (5.2x). Revenue declining -7% YoY, concerning. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.3B |
| Beta | 1.00 |
| 52W Range | $6562.85 - $8618.28 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.89 |
| Forward P/E | 17.7 |
| Current P/E | 17.4 |
| YoY Growth | -1.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.5% to -3.3% (-5.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.3pp (needs >3.0% for momentum thesis). Underperforming sector by 4.4pp, stock-specific weakness. Below SMA200 (0.97x), long-term trend not supportive. MACD histogram bearish (-16.27), momentum weakening. RSI neutral at 44. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.34% (CS: 14) | Weak |
| RSI_14 | 44.1 | Neutral |
| MACD Histogram | -16.27 | Bearish |
| vs SMA20 | 0.977x | Below |
| vs SMA50 | 0.988x | Below |
| vs SMA200 | 0.975x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $7331.05
- **Stop Loss:** $7022.93 (4.2% risk)
- **Target:** $7639.17 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 2
- **Position Value:** $14,662.10
- **Portfolio %:** 14.66%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-27 (Est: $106.21)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $109.36 | $112.33 | +2.7% |
| 2025Q2 | $106.20 | $108.54 | +2.2% |
| 2025Q1 | $106.07 | $94.83 | -10.6% |
| 2024Q4 | $129.35 | $139.93 | +8.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*